Viewing Study NCT03068351


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-01-04 @ 5:38 PM
Study NCT ID: NCT03068351
Status: COMPLETED
Last Update Posted: 2020-02-07
First Post: 2017-02-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module